PCN106 A REVIEW OF COST-EFFECTIVENESS STUDIES OF PEMBROLIZUMAB FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
Qiao, N., Insinga, R., Burke, T., Lopes, G.Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.1600
Date:
May, 2020
File:
PDF, 648 KB
2020